Lomustine

Lomustine is an oral chemotherapy medication belonging to the class of alkylating agents. It is commonly prescribed for the treatment of malignant gliomas, which are a type of cancer that arises in the glial cells of the brain or spinal cord.
Lomustine works by targeting and killing rapidly dividing cancer cells. This medication interferes with the natural process of DNA replication within these cells, leading to cell death. By destroying the rapidly growing cancer cells, Lomustine can help to slow the progression of malignant gliomas and alleviate symptoms in affected individuals.
The typical dosage and administration of Lomustine require close monitoring by healthcare professionals due to its potential side effects. Common adverse reactions may include nausea, vomiting, and fatigue. Additionally, due to its effect on rapidly dividing cells, Lomustine can suppress bone marrow function, leading to a reduction in blood cell production and an increased risk of infections.
Before beginning treatment with Lomustine, healthcare providers should thoroughly evaluate a patient’s medical history and perform necessary tests to assess their eligibility for therapy. Regular follow-ups and monitoring during treatment are crucial to ensure optimal outcomes and manage potential side effects.